PKP2 and arrhythmogenic right ventricular cardiomyopathy: Therefore, future studies should focus on uncovering whether CSN6 functions are integral to the circumvention of ARVC deficits and premature lethality associated with PKP2 gene therapy in PKP2 Hom mice.